- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05927207
Pilot Testing of a Mobile Phone App-based Intervention for Parents of Children With Autism Spectrum Disorder (ASD)
Pilot Testing of a Mobile Phone App-based Intervention for Supporting and Empowering Parents of Children With Autism Spectrum Disorder (ASD): a Mixed-method Study of Feasibility, Acceptability, and Preliminary Efficacy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Parents of autism spectrum disorder (ASD) children are often stressed about challenges in raising their children with multifaceted needs, and their stress could undermine the child's development. With the ever-increasing demand in clinical services and disruptions by the coronavirus pandemic (COVID-19), the aim of the study is to investigate the clinical efficacy of a mobile app-based intervention in reducing stress and mood symptoms, and enhancing mindfulness and competence in parents of children with ASD. The 6-week mobile app-based intervention programme, TRIP, is a structured course of mindfulness training, and knowledge and skills transfer of parenting ASD children with specific content personalised to the participant's needs, which was developed as an accessible and scalable primary-level care platform to improve the well-being of parents.
In this study, a pilot randomized waitlist-controlled trial will be conducted. 40 parents of ASD children who are ≤12 years of age and either 1. waiting for, or 2. actively receiving treatment from a regional children psychiatric specialist clinic will be recruited. Parents will be randomized into an immediate intervention arm and a waitlist arm. Feasibility, acceptability, as well as preliminary efficacy of the app will be investigated. Parental stress level, mood symptoms, competence, and level of mindfulness will be measured before, immediately after, and 2 months after the intervention with self-reported questionnaires.
The results of the proposed study will provide insights with regards to the design and implementation of the main randomised controlled trial (RCT), contributing to the generation of evidence to the real-life efficacy of a mobile app-based intervention service model to support parents of children with ASD in the era of digital mental health. As the impact of mental well-being of parents extends beyond the parents themselves, effective management of the elevated level of parental stress in ASD families is beneficial to the family functioning and long-term development of the child. The solid evidence from the main trial can also inform clinicians and service-users in choosing the evidence-based intervention suitable to their context, among the range of commercially available products with claimed efficacy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Chinese University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Chinese parents living in Hong Kong
- Parents caring for ASD children, diagnosed by clinicians according to the criteria of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and aged ≤12
- Recruited from the Child and Adolescent Psychiatric clinic at the Alice Ho Miu Ling Nethersole Hospital, a regional hospital providing the sole public child and adolescent psychiatric service in the New-Territory East Cluster of the Hospital Authority in Hong Kong
- Able to read and understand Cantonese
- Have access to an internet-enabled mobile phone with a valid phone number for the duration of the pilot trial
Exclusion Criteria:
- Parents who are not the main carer of their ASD children
- Currently receiving psychological interventions
- Undergoing mindfulness training will be excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TRIP App
Both groups will be assessed at baseline on the outcome measurements, after which the immediate intervention group will begin the 6-week intervention
|
TRIP is a mobile app-based intervention for supporting and empowering parents of children with autism spectrum disorder (ASD), comprises of a 6-week structured training on mindfulness and educational modules on ASD parenting skills.
|
|
No Intervention: Waitlist control
Both groups will be assessed at baseline on the outcome measurements, after which the the waitlist control group will receive usual care in the following six weeks.
Afterwards, the waitlist control group will complete outcome assessment once again, before receiving the 6-week intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrolment
Time Frame: Immediately post-intervention
|
Response rates during recruitment
|
Immediately post-intervention
|
|
Retention (Intervention)
Time Frame: Immediately post-intervention
|
Dropout rates from pre-intervention to immediately post-intervention
|
Immediately post-intervention
|
|
Retention (Follow-up)
Time Frame: 2 months post-intervention
|
Dropout rates from pre-intervention to 2-month post intervention
|
2 months post-intervention
|
|
Platform used
Time Frame: Immediately post-intervention
|
Platform on which the app is accessed from, Apple's iPhone operating system (iOS) or Android, will be recorded
|
Immediately post-intervention
|
|
Days of week of use
Time Frame: Immediately post-intervention
|
Whether the app is used on weekdays or weekends will be recorded
|
Immediately post-intervention
|
|
Time of day of use
Time Frame: Immediately post-intervention
|
Time of day of use (in 4-hour blocks) will be recorded
|
Immediately post-intervention
|
|
Number of app usage days
Time Frame: Immediately post-intervention
|
Number of days with logins within the 6-week intervention period
|
Immediately post-intervention
|
|
Average duration of app usage
Time Frame: Immediately post-intervention
|
Time spent in app per login within the 6-week intervention period
|
Immediately post-intervention
|
|
Number of unique components completed
Time Frame: Immediately post-intervention
|
Number of unique components completed within the 6-week intervention period
|
Immediately post-intervention
|
|
Number of core session completed
Time Frame: Immediately post-intervention
|
Number of core session completed within the 6-week intervention period
|
Immediately post-intervention
|
|
Number of optional session completed
Time Frame: Immediately post-intervention
|
Number of optional session completed within the 6-week intervention period
|
Immediately post-intervention
|
|
App usability
Time Frame: Immediately post-intervention
|
Measured by the 10-item System Usability Scale (SUS; Brooke, 1996) for assessing the usability of products and apps.
SUS scores have a range of 0 to 100, with a higher score means greater app usability.
|
Immediately post-intervention
|
|
App quality
Time Frame: Immediately post-intervention
|
Measured by the 20-item Mobile Application Rating Scale - User Version (uMARS; Stoyanov et al., 2016) that measures engagement, functionality, aesthetics, information quality of mobile health apps.
Scores range from 1 to 5, with a higher score indicating higher app quality.
|
Immediately post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental anxiety
Time Frame: Pre-intervention
|
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms.
GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
|
Pre-intervention
|
|
Parental anxiety
Time Frame: Immediately post-intervention
|
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms.
GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
|
Immediately post-intervention
|
|
Parental anxiety
Time Frame: 2-months post-intervention
|
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms.
GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
|
2-months post-intervention
|
|
Parental depression
Time Frame: Pre-intervention
|
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms.
PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
|
Pre-intervention
|
|
Parental depression
Time Frame: Immediately post-intervention
|
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms.
PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
|
Immediately post-intervention
|
|
Parental depression
Time Frame: 2-months post-intervention
|
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms.
PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
|
2-months post-intervention
|
|
Parenting stress
Time Frame: Pre-intervention
|
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction.
Scores range from 36 to 180, with higher scores indicating greater levels of stress.
|
Pre-intervention
|
|
Parenting stress
Time Frame: Immediately post-intervention
|
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction.
Scores range from 36 to 180, with higher scores indicating greater levels of stress.
|
Immediately post-intervention
|
|
Parenting stress
Time Frame: 2-months post-intervention
|
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction.
Scores range from 36 to 180, with higher scores indicating greater levels of stress.
|
2-months post-intervention
|
|
Parenting competence
Time Frame: Pre-intervention
|
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978).
Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
|
Pre-intervention
|
|
Parenting competence
Time Frame: Immediately post-intervention
|
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978).
Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
|
Immediately post-intervention
|
|
Parenting competence
Time Frame: 2-months post-intervention
|
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman; 1978).
Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
|
2-months post-intervention
|
|
Parenting efficacy
Time Frame: Pre-intervention
|
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996).
Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
|
Pre-intervention
|
|
Parenting efficacy
Time Frame: Immediately post-intervention
|
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996).
Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
|
Immediately post-intervention
|
|
Parenting efficacy
Time Frame: 2-months post-intervention
|
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996).
Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
|
2-months post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Oscar Wong, MBChB, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022.586
- 10210356 (Other Grant/Funding Number: Health and Medical Research Fund)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parent-Child Relations
-
University of LiegeActive, not recruitingParent-Child Relations | Child DevelopmentBelgium
-
McGill UniversitySave the Children; European Network of Foundations Children and Violence Evaluation... and other collaboratorsUnknown
-
University of CalgaryRecruitingParent-Child RelationsCanada
-
University of OttawaRecruitingParent-Child RelationsCanada
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Penn State UniversityActive, not recruiting
-
VISN 17 Center of ExcellenceUnited States Department of Defense; University of Texas at AustinEnrolling by invitation
-
University of AarhusCompletedParent-Child RelationsDenmark
-
Penn State UniversityCompleted
-
University of Wisconsin, MadisonLoyola University Chicago; Iowa State UniversityCompletedParent-Child Relations
Clinical Trials on TRIP
-
Boston Medical CenterBoston University; Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center and other collaboratorsCompletedCancer, BreastUnited States
-
Gaylord Hospital, IncMedstar Health Research Institute; Spaulding Rehabilitation Hospital; St. Luke...TerminatedStroke | Stroke, Acute | Gait, Unsteady | Balance; Distorted | Balance; ImpairmentUnited States
-
University Hospital, AngersRecruitingDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis | Lower Limb Trauma | Immobilisation SyndromeFrance
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Enrolling by invitationAlcohol Use, UnspecifiedUnited States
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Active, not recruiting
-
Alkermes, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruitingAlcohol Use, UnspecifiedUnited States
-
Endo PharmaceuticalsAlkermes, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Chinese University of Hong KongCompletedParent-Child Relations | Autism Spectrum DisorderHong Kong